生物活性 | |||
---|---|---|---|
描述 | ZLD1039 is a potent, highly selective, orally active EZH2 inhibitor. ZLD1039 potently and concentration-dependently inhibits the PRC2 enzyme activity of the EZH2 wild-type, Y641F, and A677G mutants, with IC50 values of 5.6 nM, 15 nM, and 4.0 nM, respectively. ZLD1039 inhibits breast tumour growth and metastasis[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.63mL 0.33mL 0.16mL |
8.16mL 1.63mL 0.82mL |
16.32mL 3.26mL 1.63mL |
参考文献 |
---|